Diane Levitan

5.6k total citations · 1 hit paper
35 papers, 2.3k citations indexed

About

Diane Levitan is a scholar working on Molecular Biology, Physiology and Aging. According to data from OpenAlex, Diane Levitan has authored 35 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Physiology and 10 papers in Aging. Recurrent topics in Diane Levitan's work include Genetics, Aging, and Longevity in Model Organisms (10 papers), Cancer Genomics and Diagnostics (8 papers) and Alzheimer's disease research and treatments (6 papers). Diane Levitan is often cited by papers focused on Genetics, Aging, and Longevity in Model Organisms (10 papers), Cancer Genomics and Diagnostics (8 papers) and Alzheimer's disease research and treatments (6 papers). Diane Levitan collaborates with scholars based in United States, Canada and France. Diane Levitan's co-authors include Iva Greenwald, Kenneth J. Kemphues, Dan T. Stinchcomb, Lynn Boyd, Su Guo, Hilda H. Slunt, Gopal Thinakaran, Michael K. Lee, Sangram S. Sisodia and Susan Bock and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Diane Levitan

34 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene

1995 582 citations Diane Levitan, Iva Greenwald Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Diane Levitan United States	21	1.1k	866	534	321	315	35	2.3k
Carole J. Proctor United Kingdom	21	1.1k 1.0×	725 0.8×	305 0.6×	121 0.4×	195 0.6×	47	2.0k
Stephen G. Dann United States	16	1.8k 1.7×	434 0.5×	86 0.2×	410 1.3×	217 0.7×	20	2.6k
David A. Lomas United Kingdom	22	1.2k 1.0×	777 0.9×	94 0.2×	525 1.6×	402 1.3×	32	2.6k
Xiaoju Max United States	4	2.3k 2.1×	337 0.4×	96 0.2×	350 1.1×	265 0.8×	8	2.9k
Scott Ogg United States	9	2.0k 1.8×	539 0.6×	1.6k 3.0×	455 1.4×	239 0.8×	9	2.9k
Sigal Gery United States	32	1.7k 1.6×	496 0.6×	243 0.5×	222 0.7×	506 1.6×	72	3.3k
Pekka Katajisto Finland	20	1.5k 1.3×	390 0.5×	240 0.4×	197 0.6×	658 2.1×	42	2.4k
Kenji Kontani Japan	32	1.7k 1.6×	300 0.3×	227 0.4×	846 2.6×	176 0.6×	68	2.8k
Gijs van Haaften Netherlands	29	1.8k 1.6×	178 0.2×	324 0.6×	208 0.6×	192 0.6×	62	2.6k
Reshma Taneja Singapore	38	3.0k 2.7×	376 0.4×	118 0.2×	211 0.7×	490 1.6×	109	4.3k

Countries citing papers authored by Diane Levitan

Since Specialization

Citations

This map shows the geographic impact of Diane Levitan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane Levitan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane Levitan more than expected).

Fields of papers citing papers by Diane Levitan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane Levitan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane Levitan. The network helps show where Diane Levitan may publish in the future.

Co-authorship network of co-authors of Diane Levitan

This figure shows the co-authorship network connecting the top 25 collaborators of Diane Levitan. A scholar is included among the top collaborators of Diane Levitan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane Levitan. Diane Levitan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fridman, Arthur, Latisha Love‐Gregory, Radha Railkar, et al.. (2025). P-2334. Clesrovimab Binding Site Conservation on the RSV F Protein: An Evaluation of RSV Molecular Sequencing Data from 2019-2023 and GenBank Sequence Analysis. Open Forum Infectious Diseases. 12(Supplement_1). 2 indexed citations

Lin, Douglas I., Júlia C.F. Quintanilha, Natalie Danziger, et al.. (2024). Pan-tumor validation of a NGS fraction-based MSI analysis as a predictor of response to Pembrolizumab. npj Precision Oncology. 8(1). 204–204. 6 indexed citations

Wei, Bo, John Kang, Miho Kibukawa, et al.. (2022). Evaluation of the TruSight Oncology 500 Assay for Routine Clinical Testing of Tumor Mutational Burden and Clinical Utility for Predicting Response to Pembrolizumab. Journal of Molecular Diagnostics. 24(6). 600–608. 28 indexed citations

Qiu, Ping, Christian Poehlein, Matthew J. Marton, Omar Laterza, & Diane Levitan. (2019). Measuring Tumor Mutational Burden (TMB) in Plasma from mCRPC Patients Using Two Commercial NGS Assays. Scientific Reports. 9(1). 114–114. 41 indexed citations

Douglas, Cameron, Daniel Holder, Randi Y. Leavitt, et al.. (2019). Letermovir Resistance Analysis in a Clinical Trial of Cytomegalovirus Prophylaxis for Hematopoietic Stem Cell Transplant Recipients. The Journal of Infectious Diseases. 221(7). 1117–1126. 57 indexed citations

Ott, Patrick A., Y-J. Bang, A.R. Abdul Razak, et al.. (2017). Relationship of PD-L1 and a T-cell inflamed gene expression profile (GEP) to clinical response in a multicohort trial of solid tumors (KEYNOTE [KN]028). Annals of Oncology. 28. v22–v22. 5 indexed citations

Kopinja, Johnny E., Raquel Sevilla, Diane Levitan, et al.. (2017). A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit. Scientific Reports. 7(1). 13853–13853. 36 indexed citations

Qiu, Ping, Gladys Arreaza, Maureen G. Maguire, et al.. (2016). Data Interoperability of Whole Exome Sequencing (WES) Based Mutational Burden Estimates from Different Laboratories. International Journal of Molecular Sciences. 17(5). 651–651. 15 indexed citations

Wei, Bo, Miho Kibukawa, Lei Chen, et al.. (2016). Development and Validation of a Template-Independent Next-Generation Sequencing Assay for Detecting Low-Level Resistance-Associated Variants of Hepatitis C Virus. Journal of Molecular Diagnostics. 18(5). 643–656. 9 indexed citations

10.

Hoefer, Heidi L. & Diane Levitan. (2013). Perforating Foreign Body in the Ventriculus of an Umbrella Cockatoo (Cacatua alba). Journal of Avian Medicine and Surgery. 27(2). 128–135. 13 indexed citations

11.

Hong, Lan, Ling Pang, Diane Levitan, et al.. (2010). Proprotein convertase subtilisin/kexin type 9 (PCSK9) affects gene expression pathways beyond cholesterol metabolism in liver cells. Journal of Cellular Physiology. 224(1). 273–281. 67 indexed citations

12.

Davis, Harry R., Paul T. Kirschmeier, Diane Levitan, et al.. (2009). An assessment of the carcinogenic potential of ezetimibe using nonclinical data in a weight-of-evidence approach. Toxicology. 258(2-3). 116–130. 21 indexed citations

13.

Levitan, Diane, et al.. (2007). Human NPC1L1 and NPC1 can functionally substitute for the ncr genes to promote reproductive development in C. elegans. Biochimica et Biophysica Acta (BBA) - General Subjects. 1770(9). 1345–1351. 14 indexed citations

14.

Vassileva, Galya, Andrei Golovko, Susan J. Abbondanzo, et al.. (2006). Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation. Biochemical Journal. 398(3). 423–430. 229 indexed citations

15.

Levitan, Diane, et al.. (2003). The Caenorhabditis elegans homolog of the putative prostate cancer susceptibility gene ELAC2, hoe-1, plays a role in germline proliferation. Developmental Biology. 266(1). 151–160. 31 indexed citations

16.

Levitan, Diane, Gang Yu, Peter St George‐Hyslop, & Caroline Goutte. (2001). APH-2/Nicastrin Functions in LIN-12/Notch Signaling in the Caenorhabditis elegans Somatic Gonad. Developmental Biology. 240(2). 654–661. 40 indexed citations

17.

Levitan, Diane, Gang Yu, Masaki Nishimura, et al.. (2000). Mutation of the conserved N-terminal cysteine (Cys92) of human presenilin 1 causes increased Aβ42 secretion in mammalian cells but impaired Notch/lin-I2 signalling in C. elegans. Neuroreport. 11(14). 3227–3230. 31 indexed citations

18.

Levitan, Diane, et al.. (2000). spr-2 , a suppressor of the egg-laying defect caused by loss of sel-12 presenilin in Caenorhabditis elegans , is a member of the SET protein subfamily. Proceedings of the National Academy of Sciences. 97(26). 14524–14529. 34 indexed citations

19.

Levitan, Diane & Iva Greenwald. (1998). LIN-12 protein expression and localization during vulval development in C. elegans. Development. 125(16). 3101–3109. 59 indexed citations

20.

Levitan, Diane & Iva Greenwald. (1995). Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature. 377(6547). 351–354. 582 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact